Clinical studies revealed high S100A8 and S100A9 serum concentrations as the best predictive biomarkers for critical COVID-19 cases and mortality [108,109,110], indicating that these endogenous ligands of TLR4 amplify also the aberrant innate anti-viral response during SARS-CoV-2 infection [111]. This evidence concerns the gene S100A8 and COVID-19.